Approximately 17.6% of patients with pancreatic cancer with high ENO1 levels were younger than 50 years of age, and 6.0% of patients with low ENO1 levels were younger than 50 years of age (χ2 = 2.807, P = 0.092; Supplementary Table S1). The gene discussed is ENO1; the disease is pancreatic neoplasm.